Discovery Research CROs
58 published
58 published CROs match Discovery Research.
Locations in this set include United States, China, United Kingdom, India, France, and Germany.
Capabilities that show up most often in this set: Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), and Oligonucleotide.
Matching companies
AAPharmaSynMedicinal chemistry CRO specializing in custom lipid synthesis, stable isotope labeling, hit-to-lead optimization, and process development for pharmaceutical and biotech clients since 2006.
AAVATAR TherapeuticsAAVATAR Therapeutics is an innovative gene therapy company developing a next-generation intelligent gene therapy platform.
AXOlabsIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.
Aliri BioanalysisBioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.
Alloy TherapeuticsProduct development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Aurigene Pharmaceutical Services LimitedIntegrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
AvantGen, Inc.AvantGen is a contract antibody discovery and engineering partner offering proprietary yeast display platforms for discovery, optimization, and development of novel antibody drugs.
Avigen LtdAvigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.
Axcelead Drug Discovery Partners, Inc.Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.
AxxamContract research organization specializing in integrated drug discovery services, from target validation to hit and lead identification across therapeutic areas.
Beantown BiotechBoston-based CRO specializing in assay development and biochemical & cellular screening for early-stage drug discovery, from target validation through lead optimization.
BioAscent DiscoveryBioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally.
BioDuro-SundiaBioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
CanAm Bioresearch Inc.Medicinal chemistry CRO offering drug discovery, custom organic synthesis, and analytical chemistry services with an all-Ph.D. team and 25+ years of experience.
Cassia, LLCCassia, LLC is a San Diego-based CRO specializing in green chemo-enzymatic synthesis of stable-isotope labeled metabolites, proteins, and nucleic acids, plus LC-MS/MS RNA modification mapping services for discovery and therapeutic development.
CertaraCertara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
ChemDivChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
ChemPartnerGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
Clutch Biotechnologies, Inc.ClutchBio provides plasmid cloning services and modular DNA design platforms for research teams with high cloning needs and rapid iteration cycles.
Markdown mirror: /services/discovery-research.md